Rights issue in Bavarian Nordic (DK) — DKK 698 million

Carnegie acted as joint global co-ordinator in the rights issue of DKK 698 million. Bavarian Nordic is a leading industrial biotechnology company developing and producing novel vaccines for the treatment and prevention of life-threatening diseases with a large unmet medical need.May, 2011.